Showing results (1291-1300 of 3,081) with videos related to
Sort By:
Pageof 309
Drug Safety|August 1, 2014
Association between statin use and Bell's palsy: a population-based studyShih-Han Hung, Li-Hsuan Wang, Herng-Ching Lin, et al.Drug Safety|August 7, 2014
Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort studyYing He, Esther W Chan, Kenneth K C Man, et al.Drug Safety|July 17, 2014
Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance databaseArnaud Pages, Emmanuelle Bondon-Guitton, Jean Louis Montastruc, et al.Drug Safety|January 19, 2013
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillanceXiaofeng Zhou, Sundaresan Murugesan, Harshvinder Bhullar, et al.Drug Safety|May 10, 2013
Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in EnglandYvonne Buggy, Victoria Cornelius, Carole Fogg, et al.Drug Safety|May 16, 2013
Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in SenegalStephanie Dellicour, Philippe Brasseur, Per Thorn, et al.Drug Safety|May 16, 2013
A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in FranceFrancesco Salvo, Florent Leborgne, Frantz Thiessard, et al.Drug Safety|April 27, 2013
Baseline correction in parallel thorough QT studiesJoanne Zhang, Qianyu Dang, Marek MalikDrug Safety|April 27, 2013
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)Rashmi R Shah, Joel Morganroth, Devron R ShahDrug Safety|April 27, 2013
Implementing ecopharmacovigilance in practice: challenges and potential opportunitiesGisela Holm, Jason R Snape, Richard Murray-Smith, et al.Pageof 309